Paul Savuto, President and CFO, and Steven Karrupan, CEO, from Blinded Diagnostics discuss Point of Care Technology at Partnerships in Clinical Trials 2012. Point of care (or decentralized testing) offers the opportunity for sponsors and Clinical Research Organizations (CROs) to perform clinical trials with testing results available in minutes rather than days. The data is available to be analyzed on site as opposed to having to ship to a central lab, cutting shipping costs. Point of care testing in clinical trials is also an excellent solution for patient enrollment and screening as well as blended studies and adaptive trials. Faster results means better opportunity for trend analysis. Point of care is also available in any location - from the isolation of a patient's home or a remote area to a large city.